Europe Veterinary Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Europe Animal Healthcare Market Report is Segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The Market Size and Value (in USD) for the Above Segments.

Europe Veterinary Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Veterinary Healthcare Market Size

View Global Report
Europe Veterinary Healthcare Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2021 - 2023
Market Size (2025) USD 12.26 Billion
Market Size (2030) USD 17.12 Billion
CAGR (2025 - 2030) 6.90 %

Major Players

Europe Veterinary Healthcare Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Veterinary Healthcare Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Veterinary Healthcare Market Analysis

The Europe Veterinary Healthcare Market size is estimated at USD 12.26 billion in 2025, and is expected to reach USD 17.12 billion by 2030, at a CAGR of 6.9% during the forecast period (2025-2030).

The major factors driving the market's growth include the rise in pet adoptions, increasing initiatives by governments and animal welfare associations, and technological advancements in the Europe Animal Healthcare Market.

In recent years, pet owners have increasingly adopted animals influenced by their interests and concerns, leading to higher demands for veterinary healthcare products in Europe, including diagnostic imaging and treatment to ensure the health and well-being of these animals. This rising pet population, coupled with changes in lifestyle patterns, increased the adoption of diagnostic imaging and Veterinary Medicine products for animals, boosting the growth of the veterinary healthcare market in Europe.

For instance, according to data updated by the European Pet Food Industry Federation (FEDIAF), Report 2023, the dog population in the region was over 66.8 million, while the cat population was over 77.9 million in Europe in 2023. According to the same source, in Poland, in 2023, over 49% of the households owned at least one dog, and over 40% owned a cat. The Global State of Pet Care report published by the HealthForAnimals Organization in September 2022 highlighted that over half a billion dogs and cats were adopted by families in Europe, along with the United States, Brazil, and China. The high pet ownership rates in Europe are driving the growth of the veterinary healthcare market by increasing the demand for Pet Healthcare therapeutics and products.

Moreover, major players in the market are working on introducing novel product launches to cater to the rising demand for Veterinary Products in the region. For instance, in April 2023, Bioberica launched its Atopivet Collar, contributing to the growing Veterinary Collars Market, as one of the first alternatives to traditional topical and oral treatments for skin diseases in Spain. The collar releases its biologically derived skin health ingredients directly onto the pet's skin, which is then spread across the body through the skin's lipids.

In conclusion, the factors mentioned above, such as the rising pet population and technological advancements by key players in the market, are expected to propel the European veterinary healthcare market's growth during the forecast period. However, counterfeit medicines and the increasing cost of animal testing and Veterinary Therapeutics are expected to hinder the market's growth during the study period.

Europe Veterinary Healthcare Industry Overview

The European veterinary healthcare market is moderately competitive, with the presence of several global and international market players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. Some of the companies that are currently dominating the market are Boehringer Ingelheim International GmbH, Ceva Sante Animale (CEVA), ECO Animal Health Group PLC, Idexx Laboratories Inc., and MSD Animal Health, which are considered Leading European Veterinary Pharmaceutical Businesses.

Europe Veterinary Healthcare Market Leaders

  1. Boehringer Ingelheim

  2. Ceva Santé Animale

  3. ECO Animal Health Group PlC

  4. Idexx Laboratories, Inc.

  5. MSD Animal Health

  6. *Disclaimer: Major Players sorted in no particular order
Europe Veterinary Healthcare Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Veterinary Healthcare Market News

  • April 2024: VolitionRx Limited, in collaboration with Antech, introduced its Nu.Q Vet Cancer Test for in-clinic use by veterinarians throughout the United States and Europe. The Nu.Q Vet Cancer Test is an affordable and accessible screening test to aid early detection. It is a blood test for dogs in breeds with an increased risk of developing cancer.
  • February 2024: VIC Group’s VIC Animal Health launched a new plant for producing sterile suspensions and powders used for treating farm animals. The company plans to produce 214,000 vials of sterile injectable suspensions, 660,000 anti-mastitis suspensions in syringes, and 142,000 vials of sterile powder.

Europe Veterinary Healthcare Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising number of Pet Adoptions
    • 4.2.2 Increasing Initiatives by Governments and Animal Welfare Associations
    • 4.2.3 Technological Advancements in Animal Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Use of Counterfeit Medicines
    • 4.3.2 Increasing Pet Care Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Therapeutics
    • 5.1.1.1 Vaccines
    • 5.1.1.2 Parasiticides
    • 5.1.1.3 Anti-infectives
    • 5.1.1.4 Medical Feed Additives
    • 5.1.1.5 Other Therapeutics
    • 5.1.2 Diagnostics
    • 5.1.2.1 Immunodiagnostic Tests
    • 5.1.2.2 Molecular Diagnostics
    • 5.1.2.3 Diagnostic Imaging
    • 5.1.2.4 Clinical Chemistry
    • 5.1.2.5 Other Diagnostics
  • 5.2 By Animal Type
    • 5.2.1 Dogs and Cats
    • 5.2.2 Horses
    • 5.2.3 Ruminants
    • 5.2.4 Swine
    • 5.2.5 Poultry
    • 5.2.6 Other Animals
  • 5.3 By Geography
    • 5.3.1 Germany
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boehringer Ingelheim International GmbH
    • 6.1.2 Ceva Sante Animale (CEVA)
    • 6.1.3 ECO Animal Health Group PLC
    • 6.1.4 Elanco
    • 6.1.5 Idexx Laboratories Inc.
    • 6.1.6 MSD Animal Health
    • 6.1.7 Vetoquinol SA
    • 6.1.8 Virbac
    • 6.1.9 Zoetis Inc.
    • 6.1.10 Hipra
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Veterinary Healthcare Industry Segmentation

As per the report's scope, veterinary healthcare can be defined as the science associated with diagnosing, treating, and preventing animal diseases. The increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. The European veterinary healthcare market is segmented by product, animal type, and geography. The product segment is further segmented into therapeutics and diagnostics. The therapeutics segment is further segmented into vaccines, parasiticides, anti-infectives, medical feed additives, and other therapeutics, while the diagnostic segment is divided into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and other diagnostics. The animal type segment is further divided into dogs and cats, horses, ruminants, swine, poultry, and other animals. The geography segment is further divided into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The report offers the value (USD) for the above segments.

By Product Therapeutics Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Product Diagnostics Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animals
By Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Veterinary Healthcare Market Research FAQs

How big is the Europe Veterinary Healthcare Market?

The Europe Veterinary Healthcare Market size is expected to reach USD 12.26 billion in 2025 and grow at a CAGR of 6.90% to reach USD 17.12 billion by 2030.

What is the current Europe Veterinary Healthcare Market size?

In 2025, the Europe Veterinary Healthcare Market size is expected to reach USD 12.26 billion.

Who are the key players in Europe Veterinary Healthcare Market?

Boehringer Ingelheim, Ceva Santé Animale, ECO Animal Health Group PlC, Idexx Laboratories, Inc. and MSD Animal Health are the major companies operating in the Europe Veterinary Healthcare Market.

What years does this Europe Veterinary Healthcare Market cover, and what was the market size in 2024?

In 2024, the Europe Veterinary Healthcare Market size was estimated at USD 11.41 billion. The report covers the Europe Veterinary Healthcare Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Europe Veterinary Healthcare Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Veterinary Healthcare Industry Report

The Europe Veterinary Healthcare market is on a trajectory of significant growth, driven by rising pet adoption rates and advancements in animal diagnostic technologies, alongside increased government initiatives aimed at improving animal health standards. Despite facing challenges such as surges in zoonotic diseases and regulatory complexities, the market is poised for expansion, fueled by growing awareness and diagnostic innovations. Germany is particularly notable for its robust demand, high pet ownership, and a thriving pet food product market. Key growth drivers include a surge in product launches and strategic collaborations enhancing the market's potential, with anti-infectives standing out due to their crucial role in combating animal diseases. The competitive landscape is vibrant, with numerous entities contributing to the sector's expansion through advancements in therapeutics and diagnostics, underpinned by strong R&D activities. Propelled by both public and private sector efforts, the Europe Veterinary Healthcare market is expected to continue its growth, ensuring the health and welfare of companion and farm animals across the continent, as detailed in Mordor Intelligence™ Industry Reports. Get a sample of this industry analysis as a free report PDF download.